NLRP3 and atherosclerosis: Given that OR6A2 lies upstream of the NLRP3 inflammasome, OR6A2 could serve as a potential therapeutic target for inflammation initiated by lipid, especially, for the prevention, treatment, and reversal of atherosclerosis.